The Imaging Wire

1 week ago | theimagingwire.com | Brian Casey

People who got evidence of their cardiovascular health from coronary CT angiography scans led healthier lifestyles compared to those who got conventional cardiac risk scoring. That’s according to a new study in JAMA Cardiology that has intriguing ramifications not only for managing heart disease but also for the imaging-based wellness industry. Cardiovascular disease is the number one killer globally, accounting for one in seven deaths.

1 week ago | theimagingwire.com | Brian Casey

An AI model for prostate MRI that combines the best features of five separate algorithms helped radiologists diagnose clinically significant prostate cancer in a new study in JAMA Network Open. The Prostate Imaging-Cancer AI consortium was formed to address a nagging problem in prostate cancer screening. Studies have shown that MRI can reduce biopsies and minimize workup of clinically insignificant disease, but it also has high inter-reader variability and requires a high level of expertise.

2 weeks ago | theimagingwire.com | Brian Casey

When it comes to informing patients of their imaging results, radiologists are caught between a rock and hard place. A new study in JACRshows how generative AI can help by drafting patient-friendly reports that are simple but accurate. Patients must be informed immediately of their medical results according to a 2021 final rule under the 21st Century Cures Act that prevents medical information blocking.

2 weeks ago | theimagingwire.com | Brian Casey

Artificial intelligence is beginning to show that it can not only detect breast cancer on mammograms, but it can predict a patient’s future risk of cancer. A new study in JAMA Network Open showed that a U.S. university’s homegrown AI algorithm worked well in predicting breast cancer risk across diverse ethnic groups. Breast cancer screening traditionally has used a one-size-fits-all model based on age for determining who gets mammography.

3 weeks ago | theimagingwire.com | Brian Casey

The American Society of Clinical Oncology’s annual meeting isn’t usually known for diagnostic radiology research. But this week’s conference in Chicago included a number of radiology-related studies, particularly regarding cancer screening. Most ASCO meetings are dominated by new chemotherapy advances. But oncologists maintain a strong interest in cancer screening as the first step to guiding patients into advanced treatments.